{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:44:19Z","timestamp":1789213459411,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T00:00:00Z","timestamp":1641600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T00:00:00Z","timestamp":1641600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00277-022-04754-6","type":"journal-article","created":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T03:02:47Z","timestamp":1641610967000},"page":"763-771","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and safety comparison between R-CHOP and modified NHL-BFM-90 regimens in children and adolescents with diffuse large B-cell lymphoma"],"prefix":"10.1007","volume":"101","author":[{"given":"Jinqiu","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Que","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijun","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,8]]},"reference":[{"issue":"19","key":"4754_CR1","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1056\/NEJM199605093341906","volume":"334","author":"JT Sandlund","year":"1996","unstructured":"Sandlund JT, Downing JR, Crist WM (1996) Non-Hodgkin's lymphoma in childhood. N Engl J Med 334(19):1238\u20131248. https:\/\/doi.org\/10.1056\/NEJM199605093341906","journal-title":"N Engl J Med"},{"issue":"1","key":"4754_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/ajh.10262","volume":"72","author":"MS Cairo","year":"2003","unstructured":"Cairo MS, Sposto R, Hoover-Regan M, Meadows AT, Anderson JR, Siegel SE et al (2003) Childhood and adolescent large-cell lymphoma (LCL): a review of the Children's Cancer Group experience. Am J Hematol 72(1):53\u201363. https:\/\/doi.org\/10.1002\/ajh.10262","journal-title":"Am J Hematol"},{"issue":"11","key":"4754_CR3","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1182\/blood.v97.11.3370","volume":"97","author":"C Patte","year":"2001","unstructured":"Patte C, Auperin A, Michon J, Behrendt H, Leverger G, Frappaz D et al (2001) The Soci\u00e9t\u00e9 Fran\u00e7aise d'Oncologie P\u00e9diatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood 97(11):3370\u20133379. https:\/\/doi.org\/10.1182\/blood.v97.11.3370","journal-title":"Blood"},{"issue":"4","key":"4754_CR4","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/bjh.14074","volume":"173","author":"J Hochberg","year":"2016","unstructured":"Hochberg J, El-Mallawany NK, Abla O (2016) Adolescent and young adult non-Hodgkin lymphoma. Br J Haematol 173(4):637\u2013650. https:\/\/doi.org\/10.1111\/bjh.14074","journal-title":"Br J Haematol"},{"issue":"8","key":"4754_CR5","doi-asserted-by":"publisher","first-page":"e27073","DOI":"10.1002\/pbc.27073","volume":"65","author":"J Hochberg","year":"2018","unstructured":"Hochberg J, Flower A, Brugieres L, Cairo MS (2018) NHL in adolescents and young adults: a unique population. Pediatr Blood Cancer 65(8):e27073. https:\/\/doi.org\/10.1002\/pbc.27073","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"4754_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1365-2141.2005.05735.x","volume":"131","author":"B Burkhardt","year":"2005","unstructured":"Burkhardt B, Zimmermann M, Oschlies I, Niggli F, Mann G, Parwaresch R et al (2005) The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Br J Haematol 131(1):39\u201349. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05735.x","journal-title":"Br J Haematol"},{"issue":"11","key":"4754_CR7","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1182\/blood.v97.11.3370","volume":"97","author":"C Patte","year":"2001","unstructured":"Patte C, Auperin A, Michon J, Behrendt H, Leverger G, Frappaz D et al (2001) The Societe Francaise d'Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood 97(11):3370\u20133379. https:\/\/doi.org\/10.1182\/blood.v97.11.3370","journal-title":"Blood"},{"issue":"3","key":"4754_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/bjh.14240","volume":"175","author":"M Pillon","year":"2016","unstructured":"Pillon M, Mussolin L, Carraro E, Conter V, Arico M, Vinti L et al (2016) Detection of prognostic factors in children and adolescents with Burkitt and diffuse large B-cell lymphoma treated with the AIEOP LNH-97 protocol. Br J Haematol 175(3):467\u2013475. https:\/\/doi.org\/10.1111\/bjh.14240","journal-title":"Br J Haematol"},{"issue":"10","key":"4754_CR9","first-page":"3294","volume":"94","author":"A Reiter","year":"1999","unstructured":"Reiter A, Schrappe M, Tiemann M, Ludwig WD, Yakisan E, Zimmermann M et al (1999) Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-M\u00fcnster Group Trial NHL-BFM 90. Blood 94(10):3294\u20133306","journal-title":"Blood"},{"issue":"3","key":"4754_CR10","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1182\/blood-2004-03-0973","volume":"105","author":"W Woessmann","year":"2005","unstructured":"Woessmann W, Seidemann K, Mann G, Zimmermann M, Burkhardt B, Oschlies I et al (2005) The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. Blood 105(3):948\u2013958. https:\/\/doi.org\/10.1182\/blood-2004-03-0973","journal-title":"Blood"},{"issue":"7","key":"4754_CR11","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1182\/blood-2006-07-036665","volume":"109","author":"MS Cairo","year":"2007","unstructured":"Cairo MS, Gerrard M, Sposto R, Auperin A, Pinkerton CR, Michon J et al (2007) Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents. Blood 109(7):2736\u20132743. https:\/\/doi.org\/10.1182\/blood-2006-07-036665","journal-title":"Blood"},{"issue":"4","key":"4754_CR12","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1002\/1097-0142(197810)42:4<1705::aid-cncr2820420408>3.0.co;2-p","volume":"42","author":"L Elias","year":"1978","unstructured":"Elias L, Portlock CS, Rosenberg SA (1978) Combination chemotherapy of diffuse histiocytic lymphoma with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP). Cancer 42(4):1705\u20131710. https:\/\/doi.org\/10.1002\/1097-0142(197810)42:4<1705::aid-cncr2820420408>3.0.co;2-p","journal-title":"Cancer"},{"issue":"12","key":"4754_CR13","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","volume":"116","author":"B Coiffier","year":"2010","unstructured":"Coiffier B, Thieblemont C, Van Den Neste E, Lepeu G, Plantier I, Castaigne S et al (2010) Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte. Blood 116(12):2040\u20132045. https:\/\/doi.org\/10.1182\/blood-2010-03-276246","journal-title":"Blood"},{"issue":"3","key":"4754_CR14","first-page":"83","volume":"102","author":"E Sabattini","year":"2010","unstructured":"Sabattini E, Bacci F, Sagramoso C, Pileri SA (2010) WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica 102(3):83\u201387","journal-title":"Pathologica"},{"issue":"3","key":"4754_CR15","first-page":"332","volume":"7","author":"SB Murphy","year":"1980","unstructured":"Murphy SB (1980) Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults. Semin Oncol 7(3):332\u2013339","journal-title":"Semin Oncol"},{"issue":"3","key":"4754_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1365-2141.2008.06988.x","volume":"142","author":"A Reiter","year":"2008","unstructured":"Reiter A, Klapper W (2008) Recent advances in the understanding and management of diffuse large B-cell lymphoma in children. Br J Haematol 142(3):329\u2013347. https:\/\/doi.org\/10.1111\/j.1365-2141.2008.06988.x","journal-title":"Br J Haematol"},{"issue":"25","key":"4754_CR17","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1200\/jco.2007.11.0700","volume":"25","author":"J Salzburg","year":"2007","unstructured":"Salzburg J, Burkhardt B, Zimmermann M, Wachowski O, Woessmann W, Oschlies I et al (2007) Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report. J Clin Oncol 25(25):3915\u20133922. https:\/\/doi.org\/10.1200\/jco.2007.11.0700","journal-title":"J Clin Oncol"},{"issue":"15","key":"4754_CR18","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","volume":"378","author":"R Schmitz","year":"2018","unstructured":"Schmitz R, Wright GW, Huang DW, Johnson CA, Phelan JD, Wang JQ et al (2018) Genetics and pathogenesis of diffuse large B-cell lymphoma. N Engl J Med 378(15):1396\u20131407. https:\/\/doi.org\/10.1056\/NEJMoa1801445","journal-title":"N Engl J Med"},{"key":"4754_CR19","unstructured":"Sun XF, Su YS, Liu DG, Jiang WQ, He YJ, Lin TY, et al. (2004) [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma]. Ai Zheng 23(8):933-8."},{"issue":"1","key":"4754_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/leu.2010.245","volume":"25","author":"B Burkhardt","year":"2010","unstructured":"Burkhardt B, Oschlies I, Klapper W, Zimmermann M, Woessmann W, Meinhardt A et al (2010) Non-Hodgkin's lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols. Leukemia 25(1):153\u2013160. https:\/\/doi.org\/10.1038\/leu.2010.245","journal-title":"Leukemia"},{"issue":"5","key":"4754_CR21","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1182\/blood-2006-08-038257","volume":"109","author":"LH Sehn","year":"2007","unstructured":"Sehn LH, Berry B, Chhanabhai M, Fitzgerald C, Gill K, Hoskins P et al (2007) The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood 109(5):1857\u20131861. https:\/\/doi.org\/10.1182\/blood-2006-08-038257","journal-title":"Blood"},{"issue":"25","key":"4754_CR22","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMoa012914","volume":"346","author":"A Rosenwald","year":"2002","unstructured":"Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI et al (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346(25):1937\u20131947. https:\/\/doi.org\/10.1056\/NEJMoa012914","journal-title":"N Engl J Med"},{"issue":"3","key":"4754_CR23","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/pbc.21619","volume":"51","author":"RR Miles","year":"2008","unstructured":"Miles RR, Raphael M, McCarthy K, Wotherspoon A, Lones MA, Terrier-Lacombe MJ et al (2008) Pediatric diffuse large B-cell lymphoma demonstrates a high proliferation index, frequent c-Myc protein expression, and a high incidence of germinal center subtype: Report of the French-American-British (FAB) international study group. Pediatr Blood Cancer 51(3):369\u2013374. https:\/\/doi.org\/10.1002\/pbc.21619","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"4754_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G et al (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103(1):275\u2013282. https:\/\/doi.org\/10.1182\/blood-2003-05-1545","journal-title":"Blood"},{"issue":"7","key":"4754_CR25","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1182\/blood-2006-07-036673","volume":"109","author":"C Patte","year":"2007","unstructured":"Patte C, Auperin A, Gerrard M, Michon J, Pinkerton R, Sposto R et al (2007) Results of the randomized international FAB\/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood 109(7):2773\u20132780. https:\/\/doi.org\/10.1182\/blood-2006-07-036673","journal-title":"Blood"},{"issue":"26","key":"4754_CR26","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1200\/JCO.20.00999","volume":"38","author":"DO Persky","year":"2020","unstructured":"Persky DO, Li H, Stephens DM, Park SI, Bartlett NL, Swinnen LJ et al (2020) Positron emission tomography-directed therapy for patients with limited-stage diffuse large B-cell lymphoma: results of Intergroup National Clinical Trials Network Study S1001. J Clin Oncol 38(26):3003\u20133011. https:\/\/doi.org\/10.1200\/JCO.20.00999","journal-title":"J Clin Oncol"},{"issue":"5","key":"4754_CR27","first-page":"314","volume":"1","author":"SL Perkins","year":"2003","unstructured":"Perkins SL, Lones MA, Davenport V, Cairo MS (2003) B-cell non-Hodgkin's lymphoma in children and adolescents: surface antigen expression and clinical implications for future targeted bioimmune therapy: a children's cancer group report. Clin Adv Hematol Oncol 1(5):314\u2013317","journal-title":"Clin Adv Hematol Oncol"},{"issue":"5","key":"4754_CR28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S1470-2045(06)70664-7","volume":"7","author":"M Pfreundschuh","year":"2006","unstructured":"Pfreundschuh M, Trumper L, Osterborg A, Pettengell R, Trneny M, Imrie K et al (2006) CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 7(5):379\u2013391. https:\/\/doi.org\/10.1016\/S1470-2045(06)70664-7","journal-title":"Lancet Oncol"},{"issue":"24","key":"4754_CR29","doi-asserted-by":"publisher","first-page":"6079","DOI":"10.1002\/cncr.27638","volume":"118","author":"RI Griffiths","year":"2012","unstructured":"Griffiths RI, Gleeson ML, Mikhael J, Dreyling MH, Danese MD (2012) Comparative effectiveness and cost of adding rituximab to first-line chemotherapy for elderly patients diagnosed with diffuse large B-cell lymphoma. Cancer 118(24):6079\u20136088. https:\/\/doi.org\/10.1002\/cncr.27638","journal-title":"Cancer"},{"issue":"2","key":"4754_CR30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s12185-018-2449-8","volume":"108","author":"Y Suzuki","year":"2018","unstructured":"Suzuki Y, Yano T, Suehiro Y, Iwasaki H, Hidaka M, Otsuka M et al (2018) Clinical characteristics and outcomes of diffuse large B-cell lymphoma in adolescents and young adults. Int J Hematol 108(2):161\u2013166. https:\/\/doi.org\/10.1007\/s12185-018-2449-8","journal-title":"Int J Hematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04754-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-022-04754-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04754-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T12:06:46Z","timestamp":1646914006000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-022-04754-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,8]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["4754"],"URL":"https:\/\/doi.org\/10.1007\/s00277-022-04754-6","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,8]]},"assertion":[{"value":"22 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Sun Yat-sen University Cancer Center (SYSUCC) Institutional Review Board and Research Ethics Committee (B2020-364). Informed consent was obtained from the parents or guardians of the patients. This study was registered at ClinicalTrials.gov Identifier NCT04726995.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}